GlobeNewswire

ORYZON Reports Third Quarter 2026 Financial Results and Provides Corporate Update
10/11/2026
Updated clinical data from three iadademstat studies to be presented at ASH 2026, including encouraging results from ALICE-2 in first-line AML (95% ORR, 84% CRc and 74% CR) and FRIDA in relapsed/refractory FLT3-mutated [...]
CHRISTUS Health among nation's most digitally advanced health systems
10/11/2026
National recognition underscores CHRISTUS Health's commitment to using technology and innovation to enhance patient outcomes and support clinicians IRVING, Texas, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CHRISTUS Health [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026
10/11/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026
10/11/2026
Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
10/11/2026
Nantes, le 10 novembre 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2026
10/11/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Krystal Biotech to Present at Upcoming Investor Conferences
10/11/2026
PITTSBURGH, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that management will take part in fireside chats and host investor meetings at the following conferences [...]
AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates
10/11/2026
Launched new corporate brand as AchieveRx, The Quit Company (Nasdaq: QUIT) Presented 52-week ORCA-OL data at the CHEST 2026 Annual Meeting showing that nearly one in three adults still smoking or vaping after a [...]
Paragon Genomics and Intelliseq Partner to Accelerate High-Throughput Pharmacogenomic Profiling
10/11/2026
Learn more about the unique PGx capabilities enabled by the collaboration in an Innovation Spotlight presentation at AMP 2026 on November 13, 2026 FREMONT, Calif. and MURRIETA, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update
10/11/2026
Dosed first patient in TEMPO-1 registrational study of sutantatug envedotin (CRB-701) in patients with 2L+ oropharyngeal cancer Reported topline data from the CANYON-1 Phase 1b obesity study of CRB-913 demonstrating [...]
TaiMed Biologics Announces Publication in The Lancet HIV of Phase 1b/2a Study of Long-Acting Dual-Antibody HIV Maintenance Regimen TMB-365/TMB-380
10/11/2026
Further analysis of previously announced Phase 2a results showed 94% of evaluable participants maintained viral suppression through 24 weeks, with no confirmed virologic failures Study evaluated TMB-365/TMB-380 without [...]
Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference
10/11/2026
BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in a fireside [...]
Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
10/11/2026
KANSAS CITY, Kan., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop next-generation [...]
MannKind to Participate in Upcoming Investor Conferences
10/11/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Chris [...]
Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London
10/11/2026
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
10/11/2026
Two major federal awards totaling nearly $16.8 million will support research over a period of up to five years, including research examining how SilverCloud by Amwell, the digital cognitive behavioral therapy program on [...]
Spyre Therapeutics to Participate in Upcoming Investor Conferences
10/11/2026
WALTHAM, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology [...]
Aradigm appoints Tim Wentworth to board of directors
10/11/2026
Former CEO of Walgreens Boots Alliance and Express Scripts brings expertise in high-cost drug management, patient pharmacy care, supply chain and purchaser economics as Aradigm scales its cell and gene therapy platform [...]
Novartis ranks first place in 2026 Access to Medicine Index
10/11/2026
Novartis retains first place ranking among 20 sector peers for efforts to improve access to medicines First company to achieve No. 1 rank across all Technical Areas since Index began in 2008, achieving R&D score [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum